Latest Data & Signals Issued

Below are some of the latest signals issued for NexImmune, Inc.

General

Signal Type Signal Value Data
Score 0.000 119 days ( 50.00 %
Last Price $0.0001 0 %
Performance History
7 Days
$0.0001 $0.0001
0%
30 Days
$0.0001000000 $0.0001
0.00000300000009%
12 Mos
$0.0002 $0.0001
-50.00%

5/18

Active Buy Signals

Specific Signals

Short Term
Net score: 29.73
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0001 - $0.0001
Trend - 3 mos -0.00000071428571 % High Width: 0.00000344496499 %
Pred. range - 3 mos $0.0000999999958 - $0.0000999999993 Low -0.00000417095969 % - -0.00000072599572 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Sell Very Low Jul 30, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low Jul 14, 2026 - 14 days
Short MA 3 mos Sell Low Jun 25, 2026 - 26 days
Long MA 3 mos Buy Medium Jul 08, 2026 - 18 days
Short/Long MA 3 mos Buy Medium Jul 14, 2026 - 14 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 37.4
Signal Type Signal Value Importance Data
Trend - 12 mos -5.28 % Very High Width: 1,973.83 %
Pred. range - 12 mos N/A - $0.91 High -100.00 % - 913,463.04 %
Short MA 12 mos Buy Very High Jul 08, 2026 - 18 days
Long MA 12 mos Sell Very High Apr 20, 2026 - 72 days
Short/Long MA 12 mos Sell Very High May 07, 2026 - 59 days
Pivot Long Buy Low Jun 04, 2026 - 40 days
RSI Long Pivot Signal Sell Low Jul 23, 2026 - 7 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Buy High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT NEXIMMUNE, INC.
NexImmune
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials f...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE